Volume 47, Issue 1 , Pages 21-31, January 2008
Misuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the Literature
To access this article, please choose from the options below
This study was funded by grants from the National Institute of Drug Abuse U10 DA15831 and U10 DA13046 , (Dr. Roger Weiss, PI); R01 DA012945 and K24 DA016264 (Dr. Timothy Wilens, PI).
Disclosure: Dr. Wilens has received research support from, has been a speaker for and served on the advisory boards of Abbott, Ortho-McNeil, Eli Lilly, GlaxoSmithKline, Merck, National Institute on Drug Abuse, Neurosearch, Novartis, Pfizer, and Shire. Dr. Adler receives and has received research support from, is and has been a speaker for, or is and has been on the advisory boards of Abbott, Bristol-Myers Squibb, Cephalon, Cortex, Eli Lilly, National Institute of Drug Abuse, Neurosearch, Novartis, McNeil/J & J, Merck, Organon, Pfizer, and Shire. The other authors report no conflicts of interest.
PII: S0890-8567(09)62081-5
doi:10.1097/chi.0b013e31815a56f1
© 2008 The American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.
Volume 47, Issue 1 , Pages 21-31, January 2008
